Page last updated: 2024-08-17

trifluridine and 9-((2-hydroxy-1,3,2-dioxaphosphorinan-5-yl)oxymethyl)guanine p-oxide

trifluridine has been researched along with 9-((2-hydroxy-1,3,2-dioxaphosphorinan-5-yl)oxymethyl)guanine p-oxide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Araullo-Cruz, T; Capone, A; Gordon, A; Gordon, YJ; Romanowski, E; Sheppard, J	1

Other Studies

1 other study(ies) available for trifluridine and 9-((2-hydroxy-1,3,2-dioxaphosphorinan-5-yl)oxymethyl)guanine p-oxide

Article	Year
2'-nor-cGMP, a new cyclic derivative of 2'NDG, inhibits HSV-1 replication in vitro and in the mouse keratitis model. Current eye research, 1987, Volume: 6, Issue:1 Topics: Acyclovir; Animals; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Eye; Ganciclovir; Guanine; Keratitis, Dendritic; Mice; Mice, Inbred BALB C; Organophosphorus Compounds; Simplexvirus; Trifluridine; Vero Cells; Virus Replication	1987

Article

Year

2'-nor-cGMP, a new cyclic derivative of 2'NDG, inhibits HSV-1 replication in vitro and in the mouse keratitis model.

Current eye research, 1987, Volume: 6, Issue:1

Topics: Acyclovir; Animals; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Eye; Ganciclovir; Guanine; Keratitis, Dendritic; Mice; Mice, Inbred BALB C; Organophosphorus Compounds; Simplexvirus; Trifluridine; Vero Cells; Virus Replication

1987